论文部分内容阅读
目的探讨免疫球蛋白(intravenous immunoglobulins,IVIG)静脉滴注治疗格林巴利综合征(Guilliain-Barre syndrome,GBS)的临床疗效。方法将46例GBS的病例,随机分为观察组24例和对照组22例。对照组采用激素等综合治疗,观察组在此基础上静脉滴注IVIG,治疗前后进行观测,记录并比较。结果治疗前两组患者差异小,治疗后观察组疗效远好于对照组。结论IVIG治疗总有效率、治愈率明显优于激素,起效快,在条件允许的情况下,应尽早应用IVIG进行治疗。但其价格昂贵,面对那些不能负担昂贵治疗费用或不能耐受的患者,激素仍是一个有价值的治疗选择。
Objective To investigate the clinical effect of intravenous infusion of intravenous immunoglobulins (IVIG) on Guilliain-Barre syndrome (GBS). Methods 46 cases of GBS were randomly divided into observation group 24 cases and control group 22 cases. Control group with hormone therapy, the observation group on the basis of intravenous IVIG, before and after treatment were observed, recorded and compared. Results Before treatment, there was little difference between the two groups of patients. After treatment, the efficacy of the observation group was much better than that of the control group. Conclusion The total effective rate of IVIG treatment, the cure rate was significantly better than the hormone, rapid onset, where conditions permit, should be treated as soon as possible IVIG. But they are expensive, and hormones remain a valuable treatment option for those who can not afford expensive treatments or intolerance.